As the global COVID-19 pandemic continues, unabated and clinical trials demonstrate limited effective pharmaceutical interventions, there is a pressing need to accelerate treatment evaluations. Among ...

As the global COVID-19 pandemic continues, unabated and clinical trials demonstrate limited effective pharmaceutical interventions, there is a pressing need to accelerate treatment evaluations. Among ...
Pharmaceutical research and development is organized around prioritized investments, delivering on assets with the greatest return of investments. Linear sequencing of trials and financial risks are d...
This commentary in Lancet discusses the need to understand the various disease states of COVID-19 when interpreting trial results. The majority of clinical trials involve patients who have been ad...
A COVID-19 call to action in Clinical Pharmacology & Therapeutics from Richard Peck, Daniel Weiner, Jack Cook and Bob Powell. “The Global Heads of Clinical Pharmacology from the pharmaceutic...
In this commentary in Clinical and Translational Science, the authors urge the global translational and quantitative pharmacology community to come together and contribute our tools and know-how to fi...
Commentary by Carl Kirkpatrick, PhD. Professor at Monash University As the number of patients diagnosed with COVID-19 exceeded the 2.5 million worldwide, the impact on the hospital systems in many cou...
Commentary by Dr. Craig Rayner and Dr. Karen Yeo Recently in Antiviral research, Caly et al.(1) reported the in vitro activity of ivermectin against SARS-CoV-2 in SERO cells. The study, described th...
Commentary by Mark Milad, PharmD Introduction According to the CDC, pregnant women seem to have the same risks from COVID-19 as adults who are not pregnant.1 However, pregnant women and newborns are...
Commentary by Tom Polasek, MD, PhD, Director of Clinical Pharmacology, Certara The high morbidity and mortality rates of COVID-19 infection in the elderly highlight the importance of clinical pharmaco...
by Dr. Keith Nieforth, Senior Director PMX-SW, Certara With the continued advancement of the COVID-19 pandemic, researchers all over the globe are dedicated to finding safe and effective treatments. W...